GEODE CAPITAL MANAGEMENT, LLC

Position in CING — Cingulate Inc.

CIK 1214717 BOSTON, MA

Position in CING

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$629,525

+$364,634 QoQ

Shares Held

101,373

+66.1% QoQ

Ownership

0.764%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $17,776,987,167 across 529 Biotechnology names. CING ranks #329 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$629,525	101,373	+66.1%	Shares	Defined	2026-05-15
2025-12-31	$264,891	61,035	+43.9%	Shares	Defined	2026-02-09
2025-09-30	$166,231	42,406	+31.9%	Shares	Defined	2025-11-12
2025-06-30	$130,874	32,156	+5.8%	Shares	Defined	2025-08-08
2025-03-31	$130,719	30,400	+11.3%	Shares	Defined	2025-05-13
2024-12-31	$134,702	27,323	-9.8%	Shares	Defined	2025-02-12
2024-06-30	$9,689	30,279	-45.7%	Shares	Defined	2024-08-09
2023-09-30	$39,558	55,795	+0.2%	Shares	Defined	2023-11-13
2023-06-30	$51,769	55,666	-47.0%	Shares	Defined	2023-08-11
2023-03-31	$103,445	105,021	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.